Ítem
Solo Metadatos
Dual Time-Point 18F-FDG PET/CT in Spinal Sarcoidosis: A Single Institution Case Series
Título de la revista
Autores
Ordóñez-Rubiano E.G.
Solano-Noguera D.F.
Row W.
Weinberg J.
Tatsui C.E.
Johnson J.M.
Gule-Monroe M.K.
Fecha
2019
Directores
ISSN de la revista
Título del volumen
Editor
Lippincott Williams and Wilkins
Buscar en:
Métricas alternativas
Resumen
Abstract
Study Design.A case series of dual time-point 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) for the diagnosis of spinal cord sarcoidosis.Objective.The aim of this study was to illustrate three cases of spinal sarcoidosis with occult presentation and subsequent identification with the use of dual time-point 18F-FDG PET/CT.Summary of Background Data.Sarcoidosis of the spinal cord is very rare and when it occurs without systemic manifestations of disease can be a challenging diagnostic dilemma frequently resulting in the need for spinal cord biopsy in order to establish a diagnosis.Methods.Case series presentation and report.Results.This manuscript presents a case series experience of dual time-point 18F-FDG PET/CT for the diagnosis of spinal cord sarcoidosis. We review the cases of three patients who presented with myelopathy and underwent 18F-FDG DTPI as part of the evaluation for enhancing spinal cord lesions of unknown etiology for 2 years at a university-based cancer hospital. 18F-FDG DTPI was vital in making the diagnosis of sarcoidosis, and in two of the cases, the patients were able to avoid biopsy, thereby avoiding potential morbidity from an invasive procedure.Conclusion.18F-FDG PET/CT imaging is a noninvasive imaging technique that can be crucial in the diagnosis of sarcoidosis of the spinal cord and help avoid unnecessary procedures.Level of Evidence: 4. © 2019 Wolters Kluwer Health, Inc. All rights reserved.
Palabras clave
Keywords
Dexamethasone , Fluorodeoxyglucose f 18 , Radiopharmaceutical agent , Adult , Aged , Article , Case report , Cerebrospinal fluid analysis , Cerebrospinal fluid cytology , Cervical spinal cord , Chronic inflammation , Clinical article , Clinical feature , Contrast enhancement , Dual time point positron emission tomography-computed tomography , Female , Functional status , Gliosis , Hand paresthesia , Human , Hypermetabolism , Invasive procedure , Limb weakness , Lower limb , Lumbar puncture , Lung parenchyma , Lymphadenopathy , Male , Maximum standardized uptake value , Medical history , Middle aged , Morbidity , Myelitis , Nuclear magnetic resonance imaging , Positron emission tomography-computed tomography , Priority journal , Pruritus , Risk factor , Sarcoidosis , Spinal cord , Spinal cord biopsy , Spinal cord disease , Spinal cord lesion , Spinal cord tumor , Spinal sarcoidosis , University hospital , Diagnostic imaging , Pathology , Positron emission tomography-computed tomography , Procedures , Sarcoidosis , Spinal cord disease , Spine disease , Adult , Female , Fluorodeoxyglucose f18 , Humans , Male , Middle aged , Positron emission tomography computed tomography , Radiopharmaceuticals , Sarcoidosis , Spinal cord diseases , Spinal diseases , Cervical , Cord lesion , Diagnosis , Enhancing lesion , Fdg pet , Lumbar , Mri , Sarcoidosis , Spinal cord , Thoracic
